Markets:

Overview

News

Currencies

International

Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.200 -0.040 (-3.23%)

Streaming Delayed Price Updated: 10:11 AM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

35 36 Next >

Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410—a Modifier Gene Therapy—in Phase 1/2 ArMaDa Study for Geographic Atrophy

April 05, 2024

From Ocugen

Via GlobeNewswire

Why Ocugen Shares Are Popping Off ↗

April 03, 2024

Ocugen shares are trading higher by 14% during Wednesday's session. The company provided an update on its business activities and financial status for 2023.

Via Benzinga

Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday ↗

April 03, 2024

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

Via Benzinga

Topics Stocks

OCUGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm

April 02, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

What's Going On With Ocugen Stock? ↗

March 26, 2024

Ocugen shares are trading lower by 6.3% during Tuesday's session. The stock is pulling back after hitting a new 52-week high Monday and following recent, key business updates.

Via Benzinga

Ocugen (OCGN) Q4 2023 Earnings Call Transcript ↗

April 02, 2024

OCGN earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

OCGN Stock Falls Ocugen Must Restate Its Financials ↗

April 02, 2024

After an impressive rally to date, investors appear to be in selling mode with OCGN stock on the news it will need to restate its financials.

Via InvestorPlace

Ocugen Provides Business Update with Certain Financials for the Year Ending 2023

April 02, 2024

Conference Call and Webcast Today at 8:30 a.m. ET

From Ocugen

Via GlobeNewswire

Earnings Scheduled For April 2, 2024 ↗

April 02, 2024

Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.

Via Benzinga

Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST—a Modifier Gene Therapy—in GARDian Study for Stargardt Disease

April 01, 2024

From Ocugen

Via GlobeNewswire

Ocugen to Host Conference Call on Tuesday, April 2 at 8:30 A.M. ET to Provide Business Update with Certain Financials for the Year Ending 2023

April 01, 2024

From Ocugen

Via GlobeNewswire

Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 01, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.

Via Benzinga

Topics Stocks

Is the Stock Market Closed on Good Friday 2024? ↗

March 25, 2024

Investors are wondering if the stock market is closed on Good Friday 2024 as they prepare for the upcoming Easter weekend.

Via InvestorPlace

Why Is Landos Biopharma (LABP) Stock Up 168% Today? ↗

March 25, 2024

Landos Biopharma stock is up on Monday as LABP investors learn about a massive acquisition deal with AbbVie that values it at $137.5 million.

Via InvestorPlace

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

Why Is Ocugen (OCGN) Stock Up 20% Today? ↗

March 25, 2024

Ocugen stock is heading higher on Friday as investors in OCGN shares react to a dismissed class action lawsuit against the company.

Via InvestorPlace

Topics Lawsuit

What's Going On With Ocugen (OCGN) Shares? ↗

March 25, 2024

Ocugen shares are trading higher by 25.6% during Monday's session. The stock is trading higher, potentially on upward momentum, following a number of key announcements last week.

Via Benzinga

3 Stocks Under $5 Ready to Outpace the Market ↗

March 25, 2024

Discover three stocks under $5 from SaaS transformation to biotech advancements, that showcase immense potential for market outperformance.

Via InvestorPlace

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 22, 2024

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Via Benzinga

Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday ↗

March 22, 2024

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Via Benzinga

Topics Stocks

Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

March 22, 2024

Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion

Via Benzinga

Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 21, 2024

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.

Via Benzinga

Guess? Posts Upbeat Earnings, Joins Lufax, Nortech Systems And Other Big Stocks Moving Higher On Thursday ↗

March 21, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 250 points on Thursday.

Via Benzinga

Topics Stocks

Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer

March 18, 2024

From Ocugen

Via GlobeNewswire

Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410

March 13, 2024

From Ocugen

Via GlobeNewswire

Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street ↗

March 07, 2024

Could these biotech companies still win in the vaccine market and beyond?

Via The Motley Fool

Ocugen to Present at Investing in Cures Summit

March 06, 2024

From Ocugen

Via GlobeNewswire

Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB

February 28, 2024

Via AB Newswire

Topics Intellectual Property

Ocugen Clinical Showcase Webcast Now Available

February 28, 2024

From Ocugen

Via GlobeNewswire

Meme Stock Meltdowns: 3 Names to Sell Before They Crash ↗

February 26, 2024

Via InvestorPlace

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.